Skip to main content

Advertisement

SpringerLink
Log in

GUROPA survey: genito-urinary radiation oncology prescription attitudes

  • RADIOTHERAPY
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Aims

To investigate the role of Radiation Oncology in the management of genito-urinary (GU) cancer excluding prostate and penile cancer.

Methods

The questionnaire was focused on the evaluation of the degree of involvement of radiation oncologists in the work-up of bladder, renal cell carcinoma and testicular cancer (TC).

Results

Eighty-eight radiation oncologists completed the survey. The majority (85.4%) of participating radiation oncologists were senior consultants (> 5 years of experience). Sixty-four (73.6%) carried out a multidisciplinary tumor board discussion of GU cases, while 23 (26.4%) did not. Seventy-five percent of responders reported that, every year, visited < 50 GU patients (pts), 18.1% visited 50–100 pts and 6.9% visited > 100 pts. Bladder cancer, curative radiotherapy (RT) as part of trimodality approach was claimed to be adopted in less than 10 cases per year. Regarding renal cell carcinoma (RCC) patients, primary tumor directed RT was adopted only in 8 cases (9.4%) in at least 10 pts per year. Palliative RT was more frequent in RCC (48.2%) in over than 10 pts per year. In case of TC, the prescription of RT was limited (< 10 patients per year) due to the low incidence of disease and recent shift to surveillance as a first option in stage I seminoma.

Conclusions

Our survey showed that radiation oncologists are rarely involved in the decision making strategy of GU cancer, despite many clinical trials support RT use. These patients probably deserve a more uniform approach based on updated, detailed and evidence-based recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30

    Article  Google Scholar 

  2. Antoni S, Ferlay J, Soerjomataram I et al (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108

    Article  PubMed  Google Scholar 

  3. Epstein JI, Amin MB, Reuter VE et al (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22:1435–1448

    Article  CAS  PubMed  Google Scholar 

  4. https://www.gov.uk/government/publications/radiotherapy-services-in-england-2012. Accessed 8 April 2018

  5. Bellmunt J, Orsola A, Leow JJ et al (2014) Bladder cancer: ESMO practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii40-8

    Article  PubMed  Google Scholar 

  6. Caffo O, Veccia A, Fellin G et al (2013) Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature. Crit Rev Oncol Hematol 86(2):176–190

    Article  PubMed  Google Scholar 

  7. Linee Guida AIRO-AIRB (2018) Neoplasie della Vescica. Tumori J (accepted)

  8. Walker M, Doiron RC, French SD et al (2017) Bladder-sparing radiotherapy for muscle-invasive bladder cancer: a qualitative study to identify barriers and enablers. Clin Oncol 2017(29):818–826

    Article  Google Scholar 

  9. Jereczek-Fossa BA, Colombo R, Magnani T et al (2015) Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy. Tumori 101(2):174–178

    Article  PubMed  Google Scholar 

  10. Alongi F, Arcangeli S, Triggiani L et al (2017) Stereotactic ablative radiation therapy in renal cell carcinoma: from oligometastatic to localized disease. Crit Rev Oncol Hematol 117:48–56

    Article  PubMed  Google Scholar 

  11. Garcia-Barros M, Paris F, Cordon-Cardo C et al (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622):1155–1159

    Article  CAS  PubMed  Google Scholar 

  12. Kulkarni GS, Hermanns T, Wei Y et al (2017) Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. J Clin Oncol 35(20):2299–2305

    Article  PubMed  Google Scholar 

  13. Scarberry K K, Ponsky L, Cherullo E et al (2018) Evaluating the impact of the genitourinary multidisciplinary tumour board: should every cancer patient be discussed as standard of care? Can Urol Assoc J. https://doi.org/10.5489/cuaj.5150

    Article  PubMed  PubMed Central  Google Scholar 

  14. Valdagni R, Van Poppel H, Aitchison M et al (2015) Prostate cancer unit initiative in Europe: a position paper by the European School of Oncology. Crit Rev Oncol Hematol 95(2):133–143

    Article  PubMed  Google Scholar 

  15. Chang SS, Bochner Bh, Chou R et al (2017) Treatment of nonmetastatic muscle-invasive bladder cancer: American Urological Association/American Society of Clinical Oncology/American Society for radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. J Oncol Pract 13(9):621–625

    Article  PubMed  Google Scholar 

  16. Baumann BC, Bosch WR, Bahl A et al (2016) Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 96(1):78–86

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fonteyne V, Dirix P, Junius S et al (2017) Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial. BMC Cancer 17(1):308

    Article  PubMed  PubMed Central  Google Scholar 

  18. Solanki AA, Martin B, Korpics M et al (2017) Adjuvant radiotherapy use by US radiation oncologists after radical cystectomy for muscle-invasive bladder cancer. Clin Oncol (R Coll Radiol) 29(7):429–435

    Article  CAS  Google Scholar 

  19. Gilson B, Lederman G, Qian G et al (2006) Hypo-fractionated stereotactic extra-cranial radiosurgery (HFSR) for primary and metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 2249(66):S349

    Article  Google Scholar 

  20. Siva S, Jackson P, Kron T et al (2016) Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: establishing a dose–response relationship. Radiother Oncol 118(3):540–546

    Article  PubMed  Google Scholar 

  21. Jereczek-Fossa BA, Bortolato B, Gerardi MA et al (in press) Radiotherapy for oligometastatic cancer: a survey among radiation oncologists of lombardy (airo-lombardy), Italy. Radiol Med (accepted)

  22. Huber J, Ihrig A, Winkler E et al (2015) Interdisciplinary counseling service for renal malignancies: a patient-centered approach to raise guideline adherence. Urol Oncol 33(1):23.e1–23.e7

    Article  Google Scholar 

  23. Gayed BA, Youssef R, Darwish O et al (2016) Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned. BMC Urol 16(1):43

    Article  PubMed  PubMed Central  Google Scholar 

  24. https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf

  25. Petrelli F, Coinu A, Cabiddu M et al (2015) Surveillance of adjuvant treatment with chemotherapy or radiotherapy in Stage 1 seminoma: a systematic review and metaanalysis of 13 studies. Clin Genitourin Cancer 13:193–198

    Article  PubMed  Google Scholar 

  26. Ke KM, Blazeby JM, Strong S et al (2013) Are multidisciplinary teams in secondary care cost-effective? A systematic review of the literature. Cost Eff Resour Alloc 11(1):7. https://doi.org/10.1186/1478-7547-11-7

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Radiation Oncology Department, Ospedale Sacro-Cuore Don Calabria, Via Don A. Sempreboni 5, 37024, Negrar, Verona, Italy

    Sergio Fersino & Filippo Alongi

  2. Radiation Oncology Department, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

    Stefano Arcangeli

  3. European Institute of Oncology, University of Milan, Milan, Italy

    Barbara Alicja Jereczek-Fossa

  4. Department of Radiation Oncology, Campus Biomedico University, Rome, Italy

    Rolando D’Angelillo

  5. Genito-Urinary Group of AIRO - Italian Association for Radiation Oncology, Rome, Italy

    Filippi Bertoni

  6. Radiosurgery and Radiotherapy Department, Istituto Clinico Humanitas Cancer Center and Research Hospital, Rozzano, Milan, Italy

    Giuseppe Roberto D’Agostino

  7. Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy

    Luca Triggiani & Stefano Maria Magrini

  8. Department of Radiation Oncology, IRCCS San Martino-IST National Cancer Research Institute and University, Genoa, Italy

    Renzo Corvò

  9. University of Brescia, Brescia, Italy

    Filippo Alongi

Authors
  1. Sergio Fersino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Arcangeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara Alicja Jereczek-Fossa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rolando D’Angelillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Filippi Bertoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giuseppe Roberto D’Agostino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luca Triggiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Renzo Corvò
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stefano Maria Magrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Filippo Alongi
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on the behalf of AIRO

Corresponding author

Correspondence to Filippo Alongi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fersino, S., Arcangeli, S., Jereczek-Fossa, B.A. et al. GUROPA survey: genito-urinary radiation oncology prescription attitudes. Radiol med 123, 879–884 (2018). https://doi.org/10.1007/s11547-018-0918-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-018-0918-z

Keywords

Search

Navigation